Unique Research · Company / Funding · October 11, 2022
On Oct 8, 2022, medical AI digital-marketing platform Qingyun Tech (清赟科技) closed a multi-$10M Series C led by Kangjun Capital, with Changling Capital following — for AI platform upgrades and county-level grassroots channel network. Founded 2017 (Shanghai); early “virtual rep” innovator. Coverage: ~400k grassroots doctors, 25k grassroots + 14k county+ hospitals; +25k doctors/mo; 120k MAU doctors; 180k TP/mo; rev +150% YoY. ~40 pharma partners incl. MSD, Merck, Pfizer, AZ, Novartis, BI. ~800 staff. 5 prior rounds. Changling MP Jiang Xiaodong: “Qingyun model” validated during pandemic for deep grassroots reach.
— END —